Comparison of two different Estrogen doses in prevention of synechia after hysteroscopic treatment of Asherman syndrom patients
Phase 2
Recruiting
- Conditions
- Asherman syndrome.Intrauterine synechiae
- Registration Number
- IRCT20141230020486N3
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
all symptomatic patients (infertility or cyclic pelvic pain) referring to gynecology clinic of Imam Reza Hospital who are diagnosed with moderate to severe Asherman syndrome.
Exclusion Criteria
Another pathology in pelvic exam
History of Uterine myoma or gynecology cancer
hormone consumption during past month
History of genital tuberculosis
contraindication for hormone therapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of people who face recurrence of synechia after treatment of Asherman syndrom. Timepoint: 2 months after using of estrogen. Method of measurement: After treatment period and and bleeding are over, all patients will again go through hysteroscopy and uterine cavity condition will be investigated.
- Secondary Outcome Measures
Name Time Method